Category: carcinoid cancer

Carcinoid and Pancreatic Neuroendocrine Tumor Cancer Survivors Share Their Journeys

The Carcinoid Cancer Foundation is pleased to announce the addition of several new Survivor Stories on its website, www.carcinoid.org.  These are stories of courageous carcinoid and pancreatic neuroendocrine tumor (NET) survivors who, in several…

California Carcinoid and Neuroendocrine Tumor Conference Scheduled for January

Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California.  The latest developments in NET cancers, including clinical trials, …

Pancreatic Neuroendocrine Tumors: A Rare Cancer

From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States.  This rare cancer is often…

New Zebra Jewelry Signature Line Available at The Barking Zebra

Suzi Garber, jewelry designer and owner of The Barking Zebra website, www.barkingzebra.net, has added a Signature Line of zebra pins, earrings, cufflinks, and charms to the collection of elegant awareness jewelry available on her website.  The jewelry…

9 Conferences for the Carcinoid and Neuroendocrine Tumor Community

If you are a carcinoid or NET cancer survivor, caregiver, family member or medical professional you can learn about what’s happening now and what’s new in carcinoid/NETs treatments, clinical trials, research, and more from specialists…

Happy 4th of July from The Carcinoid Cancer Foundation

The Carcinoid Cancer Foundation wishes all carcinoid and neuroendocrine tumor survivors, family, caregivers, friends, colleagues, and the medical community who celebrate Independence Day a happy and safe holiday.

Carcinoid Cancer Foundation’s May 2011 Symposium Now Online

The Carcinoid Cancer Foundation is pleased to share with you videos from its carcinoid/NET symposium, “Neuroendocrine Tumor Management:  The Era of Personalized Medicine,” held on May 1, 2011 at Mt. Sinai Medical Center in New York City.

Following …

Worldwide NET Cancer Awareness Day Updates

With less than five months until the second Worldwide NET Cancer Awareness Day on Thursday, November 10, 2011, there have been many exciting developments to share with the carcinoid and NET community.

The first Chinese NET website (www.net.org.tw) …

Now Recruiting: Carcinoid Syndrome Patients to Participate in Clinical Trial

Ipsen is recruiting patients with a history of carcinoid syndrome to participate in a clinical study to evaluate the effect of Somatuline® Depot (Lanreotide Autogel),  a somatostatin analog (SSTa) similar to octreotide, on the control of symptoms …

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid…